These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 17078213)
1. [Comparative efficacy of carvedilol and capoten in the treatment of an uncomplicated hypertensive crisis]. Tereshchenko SN; Dzhaiani NA; Morozova MN Ter Arkh; 2006; 78(8):26-30. PubMed ID: 17078213 [TBL] [Abstract][Full Text] [Related]
2. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey. Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007 [TBL] [Abstract][Full Text] [Related]
3. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol. Khattar RS; Senior R; Soman P; van der Does R; Lahiri A Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363 [TBL] [Abstract][Full Text] [Related]
4. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension. Ogihara T; Ikeda M; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S108-12. PubMed ID: 2454355 [TBL] [Abstract][Full Text] [Related]
5. Carvedilol prevents severe hypertensive cardiomyopathy and remodeling. Barone FC; Campbell WG; Nelson AH; Feuerstein GZ J Hypertens; 1998 Jun; 16(6):871-84. PubMed ID: 9663928 [TBL] [Abstract][Full Text] [Related]
6. [First results of open randomized clinical study of Acridilol in combination therapy of patients with arterial hypertension and obesity or type 2 diabetes (Mellitus-Open Multicenter Clinical Study ACCORD)]. Shal'nova SA; Martsevich SIu; Deev AD; Lukina IuV; Oganov RG Kardiologiia; 2008; 48(8):28-33. PubMed ID: 18789007 [TBL] [Abstract][Full Text] [Related]
7. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN). Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ; Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773 [TBL] [Abstract][Full Text] [Related]
8. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014 [TBL] [Abstract][Full Text] [Related]
9. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy. Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753 [TBL] [Abstract][Full Text] [Related]
10. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study. Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826 [TBL] [Abstract][Full Text] [Related]
11. [Provision of complex cardioprotection with the help of carvedilol in 1-2 degree arterial hypertension combined with metabolic syndrome]. Oleĭnikov VE; Matrosova IB; Eliseeva IV; Tomashevskaia IuA; Gusakovskaia LI Kardiologiia; 2009; 49(11):27-32. PubMed ID: 20001979 [TBL] [Abstract][Full Text] [Related]
12. Controlled-release carvedilol in the treatment of essential hypertension. Weber MA; Sica DA; Tarka EA; Iyengar M; Fleck R; Bakris GL Am J Cardiol; 2006 Oct; 98(7A):32L-38L. PubMed ID: 17023230 [TBL] [Abstract][Full Text] [Related]
13. Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure. Brooks DP; Short BG; Cyronak MJ; Contino LC; DiCristo M; Wang YX; Ruffolo RR Br J Pharmacol; 1993 Jun; 109(2):581-6. PubMed ID: 8102931 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of carvedilol in unstable angina pectoris. Brunner M; Faber TS; Greve B; Keck A; Schnabel P; Jeron A; Meinertz T; Just H; Zehender M Am J Cardiol; 2000 May; 85(10):1173-8. PubMed ID: 10801996 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of carvedilol in renal hypertension. A multicenter open trial. Takeda T; Kohno M; Ishii M; Kubo S; Saruta T; Mizuno Y; Fukiyama K; Fujishima M; Yoshimura M Eur J Clin Pharmacol; 1990; 38 Suppl 2():S158-63. PubMed ID: 1974508 [TBL] [Abstract][Full Text] [Related]
16. Daytime-selective antihypertensive activity of celiprolol. Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718 [TBL] [Abstract][Full Text] [Related]
17. Studies on the antihypertensive properties of carvedilol, a compound with beta-blocking and vasodilating effects. Tanaka M; Masumura H; Tanaka S; Akashi A J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S52-7. PubMed ID: 2454368 [TBL] [Abstract][Full Text] [Related]
18. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure. Lund-Johansen P; Omvik P; Nordrehaug JE; White W J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of captopril and nifedipine in black and white patients with hypertensive crisis. Damasceno A; Ferreira B; Patel S; Sevene E; Polónia J J Hum Hypertens; 1997 Aug; 11(8):471-6. PubMed ID: 9322826 [TBL] [Abstract][Full Text] [Related]
20. Association of common polymorphisms in β1-adrenergic receptor with antihypertensive response to carvedilol. Si D; Wang J; Xu Y; Chen X; Zhang M; Zhou H J Cardiovasc Pharmacol; 2014 Oct; 64(4):306-9. PubMed ID: 25291495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]